Equity Profile

PODD

Insulet Corporation

Health CareHealth Care Equipment$11.2B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Insulet Corporation (PODD) operates in the Health Care sector, specializing in innovative medical devices, particularly insulin delivery systems for diabetes management. As the demand for diabetes care solutions continues to rise, Insulet's technology plays a crucial role in improving patient outcomes and enhancing quality of life.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market share and attract new customers.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PODD Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+9.35%

Avg Stock Reaction

+1.69%

Last Quarter Recap

In Q1-2026, Insulet reported an earnings per share (EPS) of $1.42, exceeding expectations by 24.78%. However, the stock declined by 9.70% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Insulet's upcoming earnings, given its history of beating EPS estimates. However, the lack of revenue guidance raises uncertainty about future performance.

Bull Case

If Insulet continues its trend of beating EPS estimates, it could signal strong operational efficiency and robust demand for its products, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to provide clear revenue guidance or if market conditions worsen, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

What are the product adoption rates for Insulet's new devices?

Understanding how quickly new products are being adopted will provide insight into the company's growth potential and competitive positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of Insulet's new product launches on revenue growth, as historical adoption rates have shown a faster-than-expected uptake.

Supporting Evidence

Insulet has consistently beaten EPS estimates, suggesting stronger operational efficiency than anticipated.

The options market is pricing a significant move, indicating that traders expect more volatility than the historical average.

Previous quarters have shown that the stock can react positively even to modest earnings beats.

Key Risk

If product adoption rates exceed expectations, it could significantly alter the revenue outlook for the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could either reinforce the company's growth trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of $1.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.20 would raise concerns about the company's profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±21.46%

Historical Avg

±4.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.5% while PODD has averaged ±4.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

65.5%

Calls (14K)P/C Ratio: 1.72Puts (273K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Insulet beats expectations, history suggests the stock could rise by about 1.9%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If the company misses expectations, history suggests a potential decline of around 1.1%, indicating market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their adoption rates.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Any guidance on future revenue expectations.
5Discussion of customer feedback on existing products.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market share and attract new customers.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PODD Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+9.35%

Avg Stock Reaction

+1.69%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Insulet's upcoming earnings, given its history of beating EPS estimates. However, the lack of revenue guidance raises uncertainty about future performance.

Bull Case

If Insulet continues its trend of beating EPS estimates, it could signal strong operational efficiency and robust demand for its products, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to provide clear revenue guidance or if market conditions worsen, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

What are the product adoption rates for Insulet's new devices?

Understanding how quickly new products are being adopted will provide insight into the company's growth potential and competitive positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of Insulet's new product launches on revenue growth, as historical adoption rates have shown a faster-than-expected uptake.

Supporting Evidence

Insulet has consistently beaten EPS estimates, suggesting stronger operational efficiency than anticipated.

The options market is pricing a significant move, indicating that traders expect more volatility than the historical average.

Previous quarters have shown that the stock can react positively even to modest earnings beats.

Key Risk

If product adoption rates exceed expectations, it could significantly alter the revenue outlook for the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could either reinforce the company's growth trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of $1.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.20 would raise concerns about the company's profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±21.46%

Historical Avg

±4.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.5% while PODD has averaged ±4.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

65.5%

Calls (14K)P/C Ratio: 1.72Puts (273K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Insulet beats expectations, history suggests the stock could rise by about 1.9%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If the company misses expectations, history suggests a potential decline of around 1.1%, indicating market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their adoption rates.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Any guidance on future revenue expectations.
5Discussion of customer feedback on existing products.